Active

Dr. Haverbeke Chloë, ONCOLOGIE

Switched

BE0678361382

Rechtspersoon Besloten Vennootschap 1 establishment

Active for

8 year, 9 months

Registered office

Marionetten(Kor) 38

8500 Kortrijk

België

Names & denominations

Dr. Haverbeke Chloë, ONCOLOGIE

Official name

NL

Enterprise details

Enterprise type

Rechtspersoon

Legal form

Besloten Vennootschap

Legal situation

Normale toestand

Start date

6 July 2017

Contact

Not specified

Peppol

Active
0208:0678361382

Active since 2 Oct 2025

Powered by

Databakkes.be

Company info. No nonsense.

Activities

NACE-BEL activity descriptions are currently shown in Dutch. English translations are underway.

NACE-BEL activities

What does this company officially do?

86220 Main activity

Activiteiten van medisch specialisten

Activiteiten op het gebied van voeding

Overige vormen van onderwijs

Overige menselijke gezondheidszorg, n.e.g.

What are NACE codes? NACE-BEL is the Belgian version of the European activity nomenclature. Each company has at least one code indicating its main activity.

Establishments

Establishment units

Physical locations of this company

Registered office

Marionetten(Kor) 38

8500 Kortrijk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Frequently asked questions

What is the enterprise number of Dr. Haverbeke Chloë, ONCOLOGIE?
The enterprise number of Dr. Haverbeke Chloë, ONCOLOGIE is BE0678361382.
What is the address of Dr. Haverbeke Chloë, ONCOLOGIE?
The registered office of Dr. Haverbeke Chloë, ONCOLOGIE is located at Marionetten(Kor) 38, 8500 Kortrijk.
When was Dr. Haverbeke Chloë, ONCOLOGIE founded?
Dr. Haverbeke Chloë, ONCOLOGIE was founded on 6 July 2017.
What is the main activity of Dr. Haverbeke Chloë, ONCOLOGIE?
The main activity of Dr. Haverbeke Chloë, ONCOLOGIE is "Activiteiten van medisch specialisten" (NACE code 86220).
Does Dr. Haverbeke Chloë, ONCOLOGIE have a website?
No website is currently known for Dr. Haverbeke Chloë, ONCOLOGIE.